JNJ | Novo Nordisk Vs. Eli Lilly: Cheap Vs. Expensive, But No Clear Opportunity

SeekingAlpha 16 hours ago

JNJ | Johnson & Johnson Targets Procedure Growth With Bladder Cancer And Vision Advances

Yahoo 1 day ago

JNJ | J&J Stock Trading Above 200- & 50-Day SMA for 8 Months: Time to Buy?

Yahoo 1 day ago

JNJ | With Two Companies Dictating Everything, IHE Is Riskier Than Most Investors Realize

Yahoo 1 day ago

JNJ | Brokers Suggest Investing in Johnson & Johnson (JNJ): Read This Before Placing a Bet

Yahoo 1 day ago

JNJ | Johnson & Johnson (JNJ) Advances Bladder Cancer Treatment with 89% Response Rate

Yahoo 1 day ago

JNJ | Protagonist Partners With Johnson & Johnson To Compete With AbbVie's Skyrizi

SeekingAlpha 1 day ago

JNJ | 2 Safe Dividend Stocks to Buy and Hold Forever

Yahoo 1 day ago

JNJ | How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Yahoo 2 days ago

JNJ | Craig Tendler, M.D., JNJ's Former Global Head of Oncology Clinical Development, to Lead TuHURA Bioscience's VISTA Program in AML and other Blood Related Cancers

Yahoo 2 days ago

JNJ | Protagonist Therapeutics Soars as FDA Approves ICOTYDE for Plaque Psoriasis, Triggers $50M Milestone

Yahoo 3 days ago

JNJ | Jim Cramer on Johnson & Johnson: “It’s a Textbook Slowdown Stock”

Yahoo 4 days ago

JNJ | Monte Rosa J J Supply Deal Refocuses MRT 2359 Prostate Cancer Story

Yahoo 4 days ago

JNJ | Protagonist Therapeutics Stock Rallies Nearly 7% in a Week: Here's Why

Yahoo 5 days ago

JNJ | Protagonist Therapeutics (PTGX) Soars 4.7%: Is Further Upside Left in the Stock?

Yahoo 5 days ago

JNJ | Origin Materials and HP Embalagens enter PET cap distribution deal

Yahoo 5 days ago

JNJ | Johnson & Johnson Prostate Cancer Trial Adds Depth To Valuation Debate

Yahoo 5 days ago

JNJ | Barclays Sees Continued Strength in Johnson & Johnson (JNJ) Pharma Business

Yahoo 5 days ago

JNJ | GI Innovation Announces First Clinical Supply Agreement to Explore Combination Therapy for Prostate Cancer

Yahoo 5 days ago

JNJ | Origin Announces HP Embalagens as Strategic Distributor for Sustainable PET Bottlecaps

Yahoo 6 days ago

JNJ | How Much Do you Need To Invest to Make $100k On Dividends Right Now?

Yahoo 6 days ago

JNJ | Jim Cramer on Johnson & Johnson: “It Should Have Gone Higher, But It Just Shows You How Hard It Is to Buck Stagflation Theories”

Yahoo 6 days ago

JNJ | AMGN Trading Above 50 & 200-Day SMA: How to Play the Stock?

Yahoo 6 days ago

JNJ | J&J Expands New Drug Portfolio With Icotyde's FDA Approval

Yahoo 6 days ago

JNJ | Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know

Yahoo 6 days ago

JNJ | ABBV Stock Slides 5%: Is J&J's Icotyde a Threat to Skyrizi?

Yahoo 6 days ago

JNJ | Johnson & Johnson announces U.S. FDA approved Icotyde

Yahoo 6 days ago

JNJ | Barclays Maintains Equal-Weight on Johnson & Johnson, Raises Price Target to $234

Benzinga 6 days ago

JNJ | Global Intracranial Pressure Monitoring Devices Market Size/Share Worth USD 3.71 Billion by 2035 at a 7.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)

Yahoo 6 days ago

JNJ | Johnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie

Benzinga 6 days ago

JNJ | 2 Reasons to Buy Johnson & Johnson Stock Like There's No Tomorrow

Yahoo 6 days ago

JNJ | HSBC Sees Healthcare Strength, Lifts Johnson & Johnson (JNJ) Price Target

Yahoo 6 days ago

JNJ | ICOTYDE Approval Adds New Growth Angle To Johnson & Johnson Valuation Story

Yahoo 7 days ago

JNJ | Analysis-TrumpRx lists many medicines at prices higher than paid in UK

Yahoo 7 days ago

JNJ | PFE's Atirmociclib 2L Breast Cancer Study Hits Goal, Aid Pipeline Push

Yahoo 7 days ago

JNJ | J&J or Merck? Key Factors Investors Must Weigh Right Now

Yahoo 7 days ago

JNJ | FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi

CNBC 7 days ago

JNJ | Protagonist Therapeutics Announces U.S. FDA Approval of ICOTYDE(TM) (icotrokinra) for the Treatment of Moderate to Severe Plaque Psoriasis

Yahoo 7 days ago

JNJ | J&J wins FDA nod for psoriasis pill that aims to compete with top-selling injections

Yahoo 7 days ago

JNJ | FDA approval of ICOTYDE™ (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide

Yahoo 7 days ago

JNJ | Have Amazon and Nvidia become value stocks? This metric says yes.

MarketWatch 7 days ago

JNJ | Johnson & Johnson Gets FDA Approval for Icotyde in Plaque Psoriasis -- Update

MarketWatch 7 days ago

JNJ | Crossbow raises $77M for new cancer immunotherapies

Yahoo 7 days ago

JNJ | Johnson & Johnson Gets FDA OK for Icotyde in Plaque Psoriasis

MarketWatch 7 days ago

JNJ | Protagonist Therapeutics Announces FDA Approval For ICOTYDE, IL-23 Receptor Antagonist For Treatment Of Moderate-To-Severe Plaque Psoriasis; Treatment Commercialized Under License By Johnson & Johnson

Benzinga 7 days ago

JNJ | Johnson & Johnson Says FDA Approves ICOTYDE, IL-23 Receptor Antagonist For Treatment Of Moderate-To-Severe Plaque Psoriasis

Benzinga 7 days ago

JNJ | [Latest] Global Surgical Stapling Devices Market Size/Share Worth USD 10.14 Billion by 2035 at a 7.2% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Yahoo 7 days ago

JNJ | Johnson & Johnson (JNJ) Stock Slides as Market Rises: Facts to Know Before You Trade

Yahoo 7 days ago

JNJ | Why One Analyst Thinks Johnson & Johnson Reaches $280

Yahoo 8 days ago

JNJ | AbbVie Slips Below 50-Day SMA: Buy, Sell or Hold the Stock?

Yahoo 8 days ago

JNJ | 10 Health Care Stocks Whale Activity In Today's Session

Benzinga 8 days ago

JNJ | HSBC Maintains Buy on Johnson & Johnson, Raises Price Target to $280

Benzinga 8 days ago

JNJ | Mestag Therapeutics Announces $40 Million Financing and Appoints Chief Medical Officer and Chief Development Officer in Preparation to Enter the Clinic

Yahoo 8 days ago

JNJ | PJP: Healthcare Dashboard For March

SeekingAlpha 8 days ago

JNJ | Is It Time To Reassess Johnson & Johnson (JNJ) After Strong Multi Year Share Price Gains

Yahoo 8 days ago

JNJ | Johnson & Johnson (JNJ) Targets Opportunities around Multiple Myeloma with TECVAYLI

Yahoo 9 days ago

JNJ | JNJ's Bladder Cancer Therapy Meets Key Goal in Early-Stage Study

Yahoo 9 days ago

JNJ | Johnson & Johnson Drives Innovation in Pulsed Field Ablation with Peru Launch

Yahoo 9 days ago

JNJ | Monte Rosa Therapeutics Announces Clinical Supply Agreement to Support Phase 2 Trial Evaluating MRT-2359 in Combination with Apalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Yahoo 9 days ago

JNJ | Neurocrine Biosciences: The Song Remains The Same

SeekingAlpha 9 days ago

JNJ | Monte Rosa Enters Into Supply Agreement With Johnson & Johnson To Evaluate MRT-2359 In Combination With ERLEADA For Treatment Of Patients With mCRPC With AR Mutations In Planned Phase 2 Study Expected To Initiate In Q3 Of 2026

Benzinga 9 days ago

JNJ | Citi Lifts PT on Johnson & Johnson (JNJ) to $274 From $250 – Here’s Why

Yahoo 10 days ago

JNJ | Contineum Therapeutics Highlights PIPE-791 IPF Trial, J&J-Backed PIPE-307 Catalysts at Leerink Conference

Yahoo 10 days ago

JNJ | Johnson & Johnson Cancer Trial Update Puts Erda-iDRS In Valuation Focus

Yahoo 11 days ago

JNJ | Coherus Oncology Pivots to Immuno-Oncology, Touts LOQTORZI Growth and New Pipeline at Citizens Conf.

Yahoo 11 days ago

JNJ | IBRX and the BCG Shortage: A 2026 Catalyst Investors Are Tracking

Yahoo 12 days ago

JNJ | Expect Pfizer To Comeback: Take The Dividend While Waiting For Capital Appreciation

SeekingAlpha 12 days ago

JNJ | Johnson & Johnson highlights promising first-in-human Erda-iDRS (formerly TAR-210) results in intermediate-risk non-muscle-invasive bladder cancer

Yahoo 12 days ago

JNJ | Johnson & Johnson (JNJ) Could Be a Great Choice

Yahoo 12 days ago

JNJ | Johnson & Johnson Announces Its Phase 1 Trial Of Intravesical Drug-Releasing System With Erdafitinib In Participants With Intermediate-Risk And High-Risk Non–Muscle-Invasive Bladder Cancer Meets Primary Endpoint, Shows Complete, Durable Responses In Patients

Benzinga 12 days ago

JNJ | Dividend stocks are catching up to tech stocks on a key earnings metric at a critical time for the market

CNBC 12 days ago

JNJ | The 5 Safest Dividend Kings Are the Only Stocks to Buy Now

Yahoo 12 days ago

JNJ | FDA Approval Of TECNIS PureSee IOL Adds New Lens For J&J Investors

Yahoo 12 days ago

JNJ | Final Trade: JNJ, MOS, XLE

CNBC 13 days ago

JNJ | The Best Dividend Stocks to Buy and Hold Forever

Yahoo 13 days ago

JNJ | Is Bristol Myers' Deep Pipeline the Key to Future Growth?

Yahoo 13 days ago

JNJ | Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients

Yahoo 13 days ago

JNJ | Johnson & Johnson's ECNIS PureSee IOL Gets FDA's Approval For Use In Cataract Surgery

Benzinga 13 days ago

JNJ | BofA Raises Johnson & Johnson (JNJ) Price Target on Pipeline Growth

Yahoo 13 days ago

JNJ | How The Johnson & Johnson (JNJ) Narrative Is Shifting With Pipeline Rethinks And New Valuation Targets

Yahoo 13 days ago

JNJ | JNJ Seeks Label Expansion of Multiple Myeloma Drug Tecvayli in the EU

Yahoo 14 days ago

JNJ | What Happens to Dividend Income When the Next Recession Hits

Yahoo 14 days ago

JNJ | Citigroup Maintains Buy on Johnson & Johnson, Raises Price Target to $274

Benzinga 14 days ago

JNJ | Ex-Stanford Athletes’ Tampon Startup Takes on Growing Market

Yahoo 14 days ago

JNJ | Regeneron: Fairly Valued Now After A Stellar Upswing

SeekingAlpha 14 days ago

JNJ | Goldman Sachs Large Cap Equity Fund Q4 2025 Portfolio Activity

SeekingAlpha 14 days ago

JNJ | Coloplast names former J&J executive Gavin Wood as CEO

Yahoo 14 days ago

JNJ | Jim Cramer's top 10 things to watch in the stock market Wednesday

CNBC 14 days ago

JNJ | Enter the shark tank: How Kenvue innovates its operations

Yahoo 14 days ago

JNJ | How FDA Approval of TECVAYLI and DARZALEX FASPRO Combo At Johnson & Johnson (JNJ) Has Changed Its Investment Story

Yahoo 15 days ago

JNJ | Johnson & Johnson (JNJ) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

SeekingAlpha 15 days ago

JNJ | JNJ Gets EU Nod for Expanded Use of Akeega in Prostate Cancer

Yahoo 15 days ago

JNJ | Legend Biotech Q4 Earnings Call Highlights

Yahoo 15 days ago

JNJ | FDA Expands Use Of Generic Drug To Treat Autism-Linked Genetic Disorder

Benzinga 15 days ago

JNJ | What Drives Hologic's GYN Surgical Strength in a Competitive Market?

Yahoo 15 days ago

JNJ | Johnson & Johnson (JNJ) Units to Pay $65 Million in Tracleer Antitrust Class Action Settlement, Reuters Reports

Yahoo 15 days ago

JNJ | Blackstone Balances Life Sciences Bet And REIT Interest As Valuation Lags

Yahoo 15 days ago

JNJ | Johnson & Johnson (JNJ) Announces the FDA Approval of TECVAYLI® plus DARZALEX FASPRO®

Yahoo 15 days ago

JNJ | Coherus Oncology Q4 Earnings Call Highlights

Yahoo 15 days ago

JNJ | Assessing Johnson & Johnson (JNJ) Valuation As Recent Share Moves Revive Investor Interest

Yahoo 16 days ago

JNJ | Factbox-Global drugmakers rush to boost US presence as tariff threat looms

Yahoo 16 days ago

JNJ | European Commission Approves AKEEGA For The Treatment Of Patients With BRCA1/2-Mutated Metastatic Hormone-Sensitive Prostate Cancer

Benzinga 16 days ago

JNJ | Quiet Outperformance From an Overlooked Dividend ETF

Yahoo 16 days ago

JNJ | Johnson and Johnson (JNJ) Reports Positive Phase 1b Cancer Data

Yahoo 17 days ago

JNJ | 2 No-Brainer Dividend Stocks to Buy in 2026

Yahoo 17 days ago

JNJ | Johnson & Johnson (NYSE:JNJ): A Dividend King Built for Sustainable Passive Income

ChartMill 18 days ago

JNJ | Is Kenvue (KVUE) Pricing Reflect Its Post Johnson & Johnson Spin Off Prospects

Yahoo 18 days ago

JNJ | BofA Boosts Johnson & Johnson (JNJ) Price Target as Pipeline Outlook Improves

Yahoo 18 days ago

JNJ | Sector Update: Health Care Stocks Softer Late Afternoon

Yahoo 19 days ago

JNJ | Market Chatter: Johnson & Johnson Units to Pay $65 Million to Settle Tracleer Antitrust Lawsuit

Yahoo 19 days ago

JNJ | FDA vaccine head will step down in April after string of controversial decisions

CNBC 19 days ago

JNJ | Jobs Crash, War Flares: Smart Money Hides In These Stocks

Benzinga 19 days ago

JNJ | Jobs Report Just Dented Most Bulletproof Sector ETF In The Market

Benzinga 19 days ago

JNJ | Lilly (LLY) Down 3.7% Since Last Earnings Report: Can It Rebound?

Yahoo 19 days ago

JNJ | U.S. FDA Approves TECVAYLI® in Combination with DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma

Yahoo 19 days ago

JNJ | Google Grabs Attention, But Funds Go Crazy For This 'Pick-And-Shovel' AI Stock

Yahoo 19 days ago

JNJ | Will AbbVie's Neuroscience Segment Continue to Aid Top Line in 2026?

Yahoo 19 days ago

JNJ | FDA Clears Johnson & Johnson's Multiple Myeloma Combo Drug After Strong Survival Results

Benzinga 19 days ago

JNJ | Halozyme Therapeutics Announces Johnson & Johnson Gets FDA Approval For TECVAYLI In Combination With DARZALEX FASPRO To Treat Adults With Relapsed Or Refractory Multiple Myeloma

Benzinga 19 days ago

JNJ | Johnson & Johnson (JNJ) Declines More Than Market: Some Information for Investors

Yahoo 19 days ago